Risk of research and development activities falling short of plan
First written in FY2017. 4 of 5 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2026: 14 of 29 companies on the "Worse" side.
74 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「However, there is no guarantee that research and development activities will always proceed as planned. If they do not proceed according to the original schedule, they may affect operating performance and financial condition.」
The company has reaffirmed the risk that failure to meet research and development plans could affect operating performance and financial condition. - FY2021RestatedAnnual report
「However, there is no guarantee that research and development activities will always proceed as planned. If they do not proceed according to the original schedule, they may affect operating performance and financial condition.」
The company has reaffirmed the risk that failure to meet research and development plans could affect operating performance and financial condition. - FY2020RestatedAnnual report
「However, there is no guarantee that research and development activities will always proceed as planned. If they do not proceed according to the original schedule, they may affect operating performance and financial condition.」
The company has reaffirmed the risk that failure to meet research and development plans could affect operating performance and financial condition. - FY2018RestatedAnnual report
「However, there is no guarantee that research and development activities will always proceed as planned. If they do not proceed according to the original schedule, they may affect operating performance and financial condition.」
The company has restated the risk that failure to meet research and development plans could affect operating performance and financial condition. - FY2017First statedAnnual report
「There is no guarantee that research and development activities will always proceed as planned. If they do not proceed according to the original schedule, they may affect operating performance and financial condition.」
The company described the impact on operating performance and financial condition if research and development progress falls short of schedule as an independent risk.